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Abstract
Background: We aimed to investigate the preventive effect of Proanthocyanidine (PC) in the
prevention of RPE formation.
Methods: Subjects were divided into four groups each containing 10 rats. In the Control Group
(CG): RPE wasn't performed. Then subjects were followed up for three days and they were
sacrificed after the follow up period. Samplings were made from tissues for measurement of
biochemical and histopathologic parameters. In the Second Group (PCG): The same protocol as
CG was applied, except the administration of PC to the subjects. In the third RPE Group (RPEG):
Again the same protocol as CG was applied, but as a difference, RPE was performed. In the
Treatment Group (TG): The same protocol as RPEG was applied except the administration of PC
to the subjects.
Results: In RPEG group, the most important histopathological finding was severe pulmonary
edema with alveolar damage and acute inflammatory cells. These findings were less in the TG
group. RPE caused increased MDA levels, and decreased GPx, SOD and CAT activity significantly
in lung tissue.
Conclusion:  PC decreased MDA levels. Oxidative stress plays an important role in
pathophysiology of RPE and PC treatment was shown to be useful to prevent formation of RPE.
Introduction
Reexpansion pulmonary edema (RPE) is a rare and acute
rare complication, occurring after rapid reinflation of a
collapsed lung, generally encountered after evacuation of
large amount of air or fluid from the pleural space [1]. The
potentially lethal complication of RPE is unilateral lung
injury, which is initiated by cytotoxic oxygen metabolites
and associated with a temporarily influx of polymorpho-
nuclear neutrophils [1]. These toxic oxygen metabolites
may occur as a result of reoxygenation of a collapsed lung.
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Proanthocyanidine (PC) is a combination of biologically
active polyphenolic flavonoids. They include oligomeric
PC, and they have been demonstrated to exert a novel
spectrum of biological, pharmacological, therapeutic, and
chemoprotective properties against oxidative stress and
oxygen free radicals [2,3]. PC manifests its novel mecha-
nistic pathways of cardioprotection by potent hydroxyl
and other free radical scavenging abilities [4,5]. Recently
it has been emphasized that, as compared to Vitamins C,
E and β-carotene, PC provides better antioxidant efficacy
[4]. However Pataki et al., (2001) reported that PC
improves cardiac recovery during reperfusion of ischemic
conditions [5]. Based on the preventive effect of PC in this
experimental research, we aimed to investigate the possi-
ble beneficial protective effects of PC in RPE.
Methods
The study was performed in Animal Research Laboratory.
Institutional ethic committee permission was obtained
before the study. Forty adult Rates Norvecus weighing
between 150 and 170 grams were used. A commercially
available PC was obtained from GNC Bakara LTD. (PC:
100 mg, 90 capsules, Istanbul, TR).
In this experimental study, forty rats were separated into
four groups by the simple random sampling method with
each group containing ten rats.
The first group was the Control Group (CG). In this
group, no Pneumothorax (Px) and subsequent RPE was
performed. Subjects have been followed for three days. In
CG, 2 ml of 1% methylcellulose solution diluted with
0.9% NaCl to 10 ml was given for 3 days by gavage. After
the follow up period, the rats were sacrificed. Then sam-
plings from the tissues have been carried out for measure-
ment of histopathological and biochemical parameters
(superoxide dismutase (SOD), glutathion peroxidase
(GPx), catalase (CAT), malondialdehyde (MDA)) and the
results were recorded.
The second group was PC Group (PCG). The same proto-
col with CG (three days of follow up, sacrification, tissue
sampling for histopathological and biochemical analysis,
recording of results) were applied. The only difference
from CG was the administration of PC (100 mg/kg/day),
by gavage, during the 3 day follow up period. Before the
administration of PC, it was homogenized in 2 ml, 1%
methylcellulose solution and then diluted with 0.9%
NaCl to 10 ml [6].
The third group was RPE Group (RPEG). The same proto-
cols with the CG (three days of follow up, sacrification,
tissue sampling for histopathological and biochemical
analysis, and recording of results) have been applied. The
only difference from CG group was the performance of
RPE. The RPE forming protocol is summarized below (*).
Two hours after re-expansion, all rats were sacrificed and
tissue samples were taken.
The fourth group was the Treatment Group (TG); which
was designed like the combination of RPE and PC groups.
In this group, the same protocol with RPEG (Px and RPE
formation, sacrification, tissue sampling for histopatho-
logical and biochemical analysis, and data recording) was
applied, except the administration of PC, which was
started 8 h before Px application, and continued for 72
hours with the same daily doze and route as PCG. This is
summarized in Table 1.
(*) RPE Forming Protocol
We used the same RPE forming model, as our previous
study [1]. Briefly, rats were anesthetized with intraperito-
neal Ketamine Hydrocloride (Ketamine hydrochloride
solution in % 5, Parke – Davis license Eczacıbas ¸ı; Medical
Industry, Istanbul) 90 mg/kg and Xylazine (Xylazine solu-
tion in % 2, by Parke – Davis license Eczacıbas ¸ı Medical
Industry, Istanbul) 10 mg/kg. In RPEG and RPE + PCG,
pneumothorax was induced by injecting about 4 ml of air
into the thorax via percutaneous route with a 22 gauge
cannula which was placed in the right hemithorax. The
adequacy of the pneumothorax was confirmed with con-
trol X-rays in all rats (Figure 1). Thereafter, the animals
were allowed to survive for an additional 72 h. Then, in
both RPEG and TG, pneumothorax was treated by aspira-
tion of the air, quickly with a 22 gauge cannula. The ade-
quacy of the reexpansion was confirmed with control X-
rays (Figure 2) and also during sternotomy in all rats. Two
hours after reexpansion, all rats were sacrificed by giving
lethal dose of Xylazine and Ketamine. Their chests were
opened by median sternotomy, and their lungs were
removed immediately for histopathological and bio-
chemical sampling. For histopathological assessment,
Table 1: Special features in our experimental study groups are 
listed below.
Group (n) Nourishment Follow Up
(Day)
RPE procedure
(+/-)
CG 10 Rat food 3 -
PCG 10 Rat food and PC 3 -
RPEG 10 Rat food 3 +
TG 10 Rat food and PC 3 +
CG; Control Group, PCG: Proanthocyanidine Group, RPEG; 
Reexpansion Pulmonary Edema, Group. TG: Treatment, Reexpansion 
Pulmonary Edema Plus Proanthocyanidin, Group. Rat food: All animals 
were provided access to the same food (2630 kkal/kg metabolic 
energy, 21% protein, 7% cellulose, and fat 9%) for a period of 7 days. 
PC: In PCG, PC (100+/-5 mg/kg rat body weight) intake was 
performed seven days by gavage orally. In TG, PC intake was started 
8 h before pneumothorax application and continued 72 hour by the 
same doze and way of PCG. RPE procedure: This column shows 
whether reexpansion pulmonary edema was performed or not.Journal of Cardiothoracic Surgery 2009, 4:40 http://www.cardiothoracicsurgery.org/content/4/1/40
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lungs were filled with 10% buffered formalin solution via
intratracheal instillation, and were fixed in the same solu-
tion. Before fixation, one third of upper lobes of both
lungs were kept in liquid nitrogen for analysis of oxidative
stress. The RPE procedure is summarized in Figure 3.
Tissue preparation for histopathological evaluation
Lung samples were embedded in paraffin blocks. Four μm
sections were sliced from paraffin blocks and stained with
hematoxylin-eosin (HE). Pulmonary edema was evalu-
ated by a pathologist, who was blinded to groups. We
have developed a "pulmonary edema score" (PES) in
order to assess the degree of pulmonary edema. Briefly,
each animal was classified according to the presence of
above mentioned histopathological findings as minimal,
moderate and advanced. Minimal pulmonary edema
(score 1); included those with only fluid extravasations,
moderate edema (score 2); included those with fluid
extravasations and fluid in the alveoli, advanced edema
(score 3); included animals that have typical histopatho-
logical findings of pulmonary edema, and eventually
those with normal pulmonary parenchyma were classified
as score 0.
Analysis of Parameters Related to Oxidative Stress Status
Malondialdehyde (MDA) levels, Catalase (CAT), Superox-
ide Dismutase (SOD) and Glutathione Peroxidase (GPx)
activity in tissue homogenate samples were measured in
accordance with the method described in our previous
study [1]. Tissue preparation for oxidative stress status:
Tissue samples were homogenized with ice-cold KCl (1.15
%) using a glass homogenizer. The homogenates was then
centrifuged at 4400 g for 10 min at 4°C to remove the cell
debris and the obtained supernatant was used for the
determination of MDA and antioxidant enzymes. GPx
activity measurement: The reaction mixture was 50 mMol
tris buffer with pH 7.6; containing 1 mMol of Na2 EDTA,
2 mMol of reduced glutathione (GSH), 0.2 mMol of
NADPH, 4 mMol of sodium azide and 1000 U of glutath-
ione reductase (GR). 50 μL of plasma or tissue homoge-
nate and 950 μL of reaction mixture were mixed and
incubated for 5 min. at 37°C. Then the reaction was initi-
ated with 10 μL of t-butyl hydroperoxide (8 mMol) and
the decrease in NADPH absorbance was followed at 340
nm for 3 min. Enzyme activities were reported as U/g in
tissue. MDA level measurement: MDA levels were
expressed as TBARS. After the reaction of thiobarbituric
acid with MDA, the reaction product was measured spec-
The confirmation of right pneumothorax by chest X-ray Figure 1
The confirmation of right pneumothorax by chest X-
ray.
The confirmation of right re-expansion by chest X-ray Figure 2
The confirmation of right re-expansion by chest X-
ray. Re-expansion pulmonary edema is also seen.Journal of Cardiothoracic Surgery 2009, 4:40 http://www.cardiothoracicsurgery.org/content/4/1/40
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trophotometrically. Tetramethoxy propane solution was
used as a standard. SOD activity measurement: Each
homogenate was diluted 1:400 with 10 mM phosphate
buffer, pH 7.00. 25 μL of diluted hemolysate was mixed
with 850 μL of substrate solution containing 0.05 mMol
xanthine sodium and 0.025 mmol/L 2-(4-iodophenyl)-3-
(4-nitrophenol)-5- phenyltetrazolium chloride (INT) in a
buffer solution containing 50 mMol CAPS and 0.94
mMol EDTA pH 10.2. Then, 125 μL of xanthine oxidase
(80 U/L) was added to the mixture and absorbance
increase was followed at 505 nm for 3 minutes against air.
25 μL of phosphate buffer or 25 μL of various standard
concentrations in place of sample were used as blank or
standard determinations. CuZn-SOD activity was
expressed in U/g tissue. CAT activity measurement: The
reaction mixture was 50 mMol phosphate buffer pH 7.0,
10 mMol H2O2 and homogenate. The reduction rate of
H2O2 was followed at 240 nm for 30 seconds at room
temperature. Catalase activity was expressed in KU/g tis-
sue.
Statistical analysis
Statistical analysis was done to analyze each group mutu-
ally by using Kruskal-Wallis and Bonferroni-corrected
Mann-Whitney U tests. The histopathological and bio-
chemical results were expressed as the standard deviation
(min-max) and p < 0.05 was assessed as statistically signif-
icant.
Results
Histopathological evaluation
Histological parameters included normal pulmonary
parenchyma, fluid extravasations, fluid extravasations and
fluid in the alveoli, and typical pulmonary edema. The
fluid accumulation in alveoli and extravasation of fluid
were the most common findings in histopathological
examination, and these two findings represented pulmo-
nary edema. In TG, the most common findings were fluid
extravasation in the perivascular areas (Figure 4a) and
eosinophilic fluid accumulation in some of the alveolar
spaces (Figure 4b). In RPEG, the most important his-
topathological finding was severe pulmonary edema (Fig-
ure 4c) with alveolar damage and scattered acute
inflammatory cells (Figure 4d), typical for RPE. We
showed that histopathological findings of normal PCG
and CG are alike (Figure 4e, 4f). No pathologic findings
were noted during the histopathological evaluation of CG
rats' lung tissues (Figure 4f). TG had statistically signifi-
cant lower mean PES (1.00 ± 0.82) with respect to RPEG
(2,10 ± 2,74; p = 0,011). The fluid accumulations in alve-
oli and extra vascular area were significantly less in the TG.
Morphologic patterns of those obtained from sections
were summarized in Table 2.
GPx, SOD and CAT activities, and MDA levels in lung 
tissue
Oxidative stress status analysis included SOD, CAT and
GPx activity, and MDA levels. RPE caused significantly
increased MDA levels, and decreased GPx, SOD and CAT
activity in lung tissue. PC treatment decreased MDA levels,
but SOD, CAT and GPx activities were similar to those of
RPEG. MDA levels and GPx, SOD and CAT activities in
lung tissue are presented in Table 3.
Discussion
In the current study we have demonstrated that; in an ani-
mal model of RPE, malondialdehyde (MDA) level of pul-
monary parenchymal tissue, a marker of oxidative stress,
increased and antioxidant enzyme activities of GPx and
SOD decreased. Treatment with PC partially improved
decreased SOD and GPx activities, and decreased MDA
levels. PC treatment also resulted in less severe pulmonary
edema in rats with RPE. In the process of RPE, two main
contributing factors are; the amount of drained fluid or
air, and the chronicity of the lung collapse. There are other
minor contributing factors such as; reexpansion tech-
nique, pulmonary arterial hypertension, associated
hypoxemia and bronchial obstruction [7]. A lung collapse
longer than 72 hours and rapid evacuation of the fluid or
air from the pleural space leading to an end-expiratory
pleural pressure less than -20 cm H2O, is associated with
higher risk of RPE [7]. However, exact mechanisms in
The Reexpension Pulmonary Edema Procedure for RPEG  and TG Figure 3
The Reexpension Pulmonary Edema Procedure for 
RPEG and TG.Journal of Cardiothoracic Surgery 2009, 4:40 http://www.cardiothoracicsurgery.org/content/4/1/40
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(a) Fluid extravasation in the perivascular areas (arrows) in TG (HE × 100), (b) Eosinophilic fluid accumulation in some of the  alveolar spaces (arrows) in TG (HE × 200), (c) Severe pulmonary edema in RPEG, (HE × 100), (d) with alveolar damage and  scattered acute inflammatory cells, typical RPE, in RPEG (HE × 200) Figure 4
(a) Fluid extravasation in the perivascular areas (arrows) in TG (HE × 100), (b) Eosinophilic fluid accumulation 
in some of the alveolar spaces (arrows) in TG (HE × 200), (c) Severe pulmonary edema in RPEG, (HE × 100), 
(d) with alveolar damage and scattered acute inflammatory cells, typical RPE, in RPEG (HE × 200). (e) Normal 
pulmoner histological structures in PCG (HE × 200) and (f) in CG also seen HE × 200).Journal of Cardiothoracic Surgery 2009, 4:40 http://www.cardiothoracicsurgery.org/content/4/1/40
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pathophysiology of RPE have not been fully understood
yet. Recent studies have demonstrated that several mech-
anisms; such as excessive negative pressure, increase in
pulmonary vascular permeability and capillary pressure of
the lung, mechanical damage of alveoli due to abrupt dis-
tension, loss of surfactant, migration of inflammatory
cells, release of inflammatory mediators, increase of
cytokines and free radicals probably due to hypoxic injury
of the atelectatic lung may be involved in pathogenesis of
RPE [6,8-11]. More than one century ago, Reisman and
Hartkey used the terms of "albuminous expectoration"
and "albumin sputum" in cases that developed pulmo-
nary edema after removal of a large amount of pleural
fluid [7,12]. These observations have been the first data,
explaining mechanism of RPE, which reflect marked
increase in lung microvascular permeability. The altera-
tion of microvascular permeability may be due to two
main causes; one of them is mechanical destruction of
alveolar wall by abrupt distension [7], and second mech-
anism, probably more dominant, is ischemic-reperfusion
injury, which may occur in many other organs [[10,11],
and [12]]. During reperfusion of the lung, free radicals,
lipid and polypeptide mediators increase, which cause the
endothelium to damage, with a subsequent increase in
vascular permeability [11,12]. A study evaluating edema-
tous fluids in two patients with RPE reported the fluid/
plasma ratio of total protein concentration to be higher
than 0.7, indicating an increase in vascular permeability
and this result has also been confirmed by the increase in
polymorphonuclear leukocytes (PMNL) and some arachi-
donic acid metabolites [9]. They have also suggested that
re-expansion of the collapsed lung causes acute inflamma-
tion in the lungs, and PMNLs play an important role in
the mechanism of the increase in pulmonary microvascu-
lar permeability. An animal study has shown that PMNLs
and pro-inflammatory cytokines, interleukin (IL) 8 and
monocyte chemoattractant protein 1, are involved in the
development of RPE [13,14]. Furthermore, some studies
have shown that; hypoxia-reoxygenation injury of one
lung may cause acute respiratory distress syndrome
(ARDS) in the other, along with systemic multi-organ
injuries [15]. According to a study it is suggested that;
pathophysiology of RPE was very similar to that of ARDS,
since both were characterized by intra-alveolar activated
PMNLs and markedly increased lung microvascular per-
meability [12]. Reactive oxygen species might also have a
role in the development of RPE, probably by causing
PMNL influx to the lungs and causing endothelial damage
[16,17]. A study group reported that; reexpansion of the
collapsed lung with air causes marked PMNL accumula-
tion and reactive oxygen species (ROS) production, and
the latter was minimal in case of reexpansion of the lungs
with nitrogen [16]. It was also reported that; activation of
sequestered PMNLs in the pulmonary circulation caused
Table 2: Histopathologic results of lung tissue.
Histological findings CG
n = 10
PCG
n = 10
RPEG
n = 10
TG
n = 10
Normal pulmonary parenchyma (edema score 0) 10 10 0 3
Fluid extravasations (edema score 1) 0 0 2 4
Fluid extravasations and fluid in the alveoli (edema score 2) 0 0 5 3
Pulmonary edema (edema score 3) 0 0 3 0
Mean pulmonary edema score 0 0 2,10 ± 2,74* 1,00 ± 0,82*
* p = 0,011
CG; Control Group, PCG: Proanthocyanidine Group, RPEG; Reexpansion Pulmonary Edema Group, TG: Treatment, Reexpansion Pulmonary 
Edema Plus Proanthocyanidin, Group.
Table 3: Oxidative stress related parameters of the lung tissue.
Parameters CG PCG RPEG TG Significance
CG-PCG CG-RPEG CG- TG RPEG- RPE + PC
MDA (nmol/g) 6.56 ± 0.15 6.45 ± 0.12 7.47 ± 0.17 7.03 ± 0.29 NS p < 0.001 p = 0.002 p < 0.001
GPx (U/g) 48.24 ± 2.97 48.21 ± 2.78 35.12 ± 2.54 38.21 ± 4.53 NS p < 0.001 P < 0.001 NS
CAT U/g) 3.27 ± 0.22 3.31 ± 0.24 3.01 ± 0.48 3.05 ± 0.74 NS NS NS NS
SOD (U/g) 255.31 ± 13.45 265.31 ± 11.42 109.23 ± 4.34 134.25 ± 19.73 NS p < 0.001 P < 0.001 p = 0.002
CG; Control Group, PCG: Proanthocyanidine Group, RPEG; Reexpansion Pulmonary Edema Group, TG: Reexpansion Pulmonary Edema Plus 
Proanthocyanidin Group. MDA; Malondialdehyde, CAT; Catalase, SOD; Superoxide Dismutase, GPx; Glutathione Peroxides. NS: Not Significant.Journal of Cardiothoracic Surgery 2009, 4:40 http://www.cardiothoracicsurgery.org/content/4/1/40
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the release of ROS [18]. These data indicate that an
inflammatory process, in which oxidative stress is
involved, play a key role in the increase of lung capillary
permeability and the consequent development of RPE.
MDA is a lipid peroxidation product and frequently used
as a marker of oxidative stress [19]. SOD, which functions
as the primary enzymatic defense against superoxide rad-
icals, catalase and GPx both of which decompose hydro-
gen peroxide to form water and oxygen, are the most
commonly examined antioxidant enzymes [19]. The
decrease in these antioxidant enzyme activities indicate
oxidant/antioxidant imbalance in favor of oxidants, i.e.
oxidative stress. In our animal model of RPE, increase in
MDA and decrease in SOD and GPx supports, from
another point of view, the suggestion that oxidative stress
play a key role in RPE pathophysiology. PC is oligomeric
and polymeric end products of the flavonoid biosynthesis
pathway, and is present in fruits, bark, leave and seeds of
many plants and grape seeds as well [2,3]. PC has antibac-
terial, antiviral, anticarcigogenic, anti-inflammatory, anti-
allergic, vasodilator and free radical scavenging activities
[2-4]. More importantly, regarding the pathophysiology
of RPE, it has also been shown to inhibit lipid peroxida-
tion, capillary permeability, inflammatory enzymes of
arachidonic acid metabolism and formation of IL-6 and
IL-8, latter of which involve in RPE development [[2,20],
and [21]]. Moreover, in vitro studies of PC extract demon-
strated better anti oxidant activity than vitamin C, vitamin
E and beta carotene and their combinations [21-23]. PC
preferentially binds to areas with high glycosaminoglycan
content, such as capillary wall and consequently decreases
vascular permeability, enhances capillary strength and
vascular function [2]. These data might be the explanation
of finding that PC treatment leads to less pulmonary
edema in the animal model of RPE. Despite the beneficial
effects of PC as mentioned above, we had some doubts
about the possible harmful effects of it on lung tissue. For
this reason, we formed another group, namely PCG,
which we only administrated PC. At the end, by compar-
ing the histopathological findings of PCG and CG, no sig-
nificant evidence have been found supporting any kind of
harmful effect of PC on lung tissue. In conclusion, we
have suggested that oxidative stress involves in patho-
physiology of RPE, and PC treatment may prevent forma-
tion of RPE partially, or decrease the intensity of RPE by
its antioxidant activity. Our point was to show the benefi-
cial effects of PC in RPE, like protection and prevention,
therefore, we used a single dosage and time schedule. In
order to answer various questions that can be asked about
the more effective usage of the molecule, we need to set
further experiments related to some factors like proper
treatment dosage, suitable way of administration, and
most appropriate interval of treatment.
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